Beyer, J <br/><br/>
Nephrotoxicity after high-dose carboplatin, etoposide and ifosfamide in germ-cell tumors: incidence and implications for hematologic recovery and clinical outcome.  [electronic resource] 

 -  Bone marrow transplantation  Nov 1997 
 - 813-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article 
<br/><br/><label>ISSN: </label>0268-3369 
<br/><br/><label>Standard No.: </label>10.1038/sj.bmt.1700980  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Kidney Injury--chemically induced<br/>Adult<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Bone Marrow Diseases--chemically induced<br/>Bone Marrow Transplantation<br/>Carboplatin--administration & dosage<br/>Cisplatin--adverse effects<br/>Combined Modality Therapy<br/>Etoposide--administration & dosage<br/>Germinoma--complications<br/>Hematopoietic Cell Growth Factors--therapeutic use<br/>Hematopoietic Stem Cell Transplantation<br/>Humans<br/>Ifosfamide--administration & dosage<br/>Male<br/>Mediastinal Neoplasms--complications<br/>Middle Aged<br/>Multiple Organ Failure--mortality<br/>Renal Dialysis<br/>Retroperitoneal Neoplasms--complications<br/>Salvage Therapy<br/>Survival Analysis<br/>Testicular Neoplasms--complications<br/>Treatment Outcome